Maximo Pettarin

Lead and support PBPK/PBBM modeling projects with pharmaceutical companies, academic partners and regulatory agencies. Develop, qualify and apply mechanistic models for early and late phase model-informed drug development, generic development, among other applications. Serve as technical lead, communicate results to clients and stakeholders, contribute to proposals, reports and publications, mentor junior colleagues, and use R and Python for data processing and workflow automation.

Doctoral research focused on the development and application of combined in vitro–in silico approaches to predict the pharmacokinetics and oral performance of biopharmaceutically challenging compounds. Thesis: “Application of In Vitro Dissolution Testing and Physiologically Based Biopharmaceutics Modelling (PBBM) in Early Drug Development – Case Study: BCS Class II/IV Drug Albendazole.” Graduated magna cum laude.